Human CYP2C19,High-Reductase+b5

Product Specifications

UNSPSC Description

Human CYP2C19, High-Reductase+b5, a recombinant CYP2C19, is a member of the CYP enzyme family. CYP2C19 catalyzes metabolism of xenobiotics, including some proton pump inhibitors and antiepileptic drugs[1].

Target Antigen

Cytochrome P450

Type

Enzyme

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/human-cyp2c19-high-reductase-b5.html

Smiles

[HumanCYP2C19,High-Reductase+b5]

References & Citations

[1]Vignaux PA, et al. Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate Pesticides. Chem Res Toxicol. 2023 Sep 18;36(9):1451-1455.